Table 2.
The relationship between hsa_circ_0124554 expression (2-ΔΔCt) and clinicopathological features in colorectal cancer patients.
| Clinicopathological factor | No of cases | Hsa_circ_0124554 expression level | P value | |
|---|---|---|---|---|
| High(%) | Low(%) | |||
| All cases | 40 | 20 (50.0) | 20 (50.0) | |
| Age (yr) | >.999 | |||
| <60 | 9 | 4 (44.4) | 5 (55.6) | |
| ≥60 | 31 | 16 (51.6) | 15 (48.4) | |
| Gender | .744 | |||
| Male | 25 | 13 (52.0) | 12 (48.0) | |
| Female | 15 | 7 (46.7) | 8 (53.3) | |
| Diameter(cm) | .337 | |||
| ≥5 | 17 | 7 (41.2) | 10 (58.8) | |
| <5 | 23 | 13 (56.5) | 10 (43.5) | |
| Differentiation | .001 | |||
| Well and moderate | 29 | 10 (34.5) | 19 (65.5) | |
| Poor | 11 | 10 (90.9) | 1 (9.1) | |
| Lymphatic metastasis | .752 | |||
| Positive | 19 | 10 (52.6) | 9 (47.4) | |
| Negative | 21 | 10 (47.6) | 11 (52.4) | |
| Lymphovascular invasion | .057 | |||
| Present | 18 | 12 (66.7) | 6 (33.3) | |
| Absent | 22 | 8 (36.4) | 14 (63.6) | |
| Perineural invasion | .018 | |||
| Present | 13 | 10 (76.9) | 3 (23.1) | |
| Absent | 27 | 10 (37.0) | 17 (63.0) | |
| Distant metastasis | .487 | |||
| M0 | 38 | 18 (47.4) | 20 (52.6) | |
| M1 | 2 | 2 (100.0) | 0 (0) | |
| Invasion | .044 | |||
| Tis-T2 | 8 | 1 (12.5) | 7 (87.5) | |
| T3-T4 | 32 | 19 (59.4) | 13 (40.6) | |
| TNM stage | .525 | |||
| 0-II | 22 | 10 (45.5) | 12 (54.5) | |
| III-IV | 18 | 10 (55.6) | 8 (44.4) | |
| Primary tumor site | .519 | |||
| Colon | 24 | 11 (45.8) | 13 (54.2) | |
| Rectum | 16 | 9 (56.3) | 7 (43.8) | |
| CEA in μg/L | >.999 | |||
| ≥5 | 18 | 9 (50.0) | 9 (50.0) | |
| <5 | 22 | 11 (50.0) | 11 (50.0) | |
| CA19-9 in U/mL | >.999 | |||
| ≥25 | 10 | 5 (50.0) | 5 (50.0) | |
| <25 | 30 | 15 (50.0) | 15 (50.0) | |
The bold symbol means statistical significance.
CA19-9 = carbohydrate antigen 19-9, CEA = carcinoembryonic antigen, TNM = tumor node metastasis.